Novartis Agrees to Sell Entire Stake in Indian Unit to WaveRise Consortium
Swiss drugmaker Novartis announced on Friday the sale of its 70.68 percent stake in its Indian arm. The buyer is a consortium led by WaveRise Investments.
洞察:
Novartis AG announced today, February 20, 2026, that it will sell its entire 70.68% stake in its listed Indian unit to a consortium of WaveRise Investments, ChrysCapital, and Two Infinity Partners. This announced sale will result in the transfer of majority ownership of the Indian unit and will fundamentally alter the ownership structure of the pharmaceutical company, which is based in Switzerland 
CH.
CH.
